BRK-B vs COHN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
COHN presents a classic deep-value opportunity with a Piotroski F-Score of 4/9 indicating stable financial health and a current price ($21.88) trading significantly below both its Graham Number ($53.43) and Intrinsic Value ($30.45). The company exhibits explosive revenue growth (493.40% YoY) and an exceptional ROE of 41.51%, though these are offset by high leverage (Debt/Equity 4.41). While technical trends and insider sentiment are currently bearish, the fundamental valuation gap and profitability metrics suggest significant upside potential.
Compare Another Pair
Related Comparisons
BRK-B vs COHN: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Cohen & Company Inc. (COHN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.